nodes	percent_of_prediction	percent_of_DWPC	metapath
Bortezomib—PTGS1—chronic kidney failure	0.207	0.293	CbGaD
Bortezomib—CYP2C19—chronic kidney failure	0.19	0.269	CbGaD
Bortezomib—CYP1A1—chronic kidney failure	0.189	0.268	CbGaD
Bortezomib—CYP3A4—chronic kidney failure	0.121	0.171	CbGaD
Bortezomib—CYP2C9—cardial valve—chronic kidney failure	0.00658	0.0613	CbGeAlD
Bortezomib—CTSG—blood plasma—chronic kidney failure	0.0049	0.0456	CbGeAlD
Bortezomib—CTSG—cardiovascular system—chronic kidney failure	0.00227	0.0211	CbGeAlD
Bortezomib—CTSG—urethra—chronic kidney failure	0.00226	0.021	CbGeAlD
Bortezomib—PSMA1—renal system—chronic kidney failure	0.0022	0.0205	CbGeAlD
Bortezomib—PSMA1—cardiovascular system—chronic kidney failure	0.00218	0.0203	CbGeAlD
Bortezomib—PSMD1—nephron tubule—chronic kidney failure	0.00204	0.019	CbGeAlD
Bortezomib—PSMA1—gonad—chronic kidney failure	0.00198	0.0184	CbGeAlD
Bortezomib—CYP2C19—urine—chronic kidney failure	0.00183	0.0171	CbGeAlD
Bortezomib—PSMD1—urethra—chronic kidney failure	0.00182	0.0169	CbGeAlD
Bortezomib—PSMA1—digestive system—chronic kidney failure	0.00181	0.0168	CbGeAlD
Bortezomib—PSMD2—nephron tubule—chronic kidney failure	0.0018	0.0168	CbGeAlD
Bortezomib—CTSG—blood—chronic kidney failure	0.00179	0.0167	CbGeAlD
Bortezomib—PSMD1—cortex of kidney—chronic kidney failure	0.00174	0.0162	CbGeAlD
Bortezomib—PSMD2—renal system—chronic kidney failure	0.00164	0.0153	CbGeAlD
Bortezomib—PSMD2—cardiovascular system—chronic kidney failure	0.00162	0.0151	CbGeAlD
Bortezomib—PSMD2—urethra—chronic kidney failure	0.00161	0.015	CbGeAlD
Bortezomib—PSMB8—urethra—chronic kidney failure	0.0016	0.0149	CbGeAlD
Bortezomib—PSMD2—kidney—chronic kidney failure	0.00159	0.0148	CbGeAlD
Bortezomib—PSMB5—nephron tubule—chronic kidney failure	0.00158	0.0148	CbGeAlD
Bortezomib—PSMD2—cortex of kidney—chronic kidney failure	0.00154	0.0144	CbGeAlD
Bortezomib—PSMB8—cortex of kidney—chronic kidney failure	0.00153	0.0143	CbGeAlD
Bortezomib—CYP1A2—urine—chronic kidney failure	0.0015	0.0139	CbGeAlD
Bortezomib—PSMD2—gonad—chronic kidney failure	0.00147	0.0137	CbGeAlD
Bortezomib—PSMD1—blood—chronic kidney failure	0.00145	0.0135	CbGeAlD
Bortezomib—CYP2C9—urine—chronic kidney failure	0.00142	0.0132	CbGeAlD
Bortezomib—PSMB5—urethra—chronic kidney failure	0.00141	0.0132	CbGeAlD
Bortezomib—PSMB1—nephron tubule—chronic kidney failure	0.00138	0.0129	CbGeAlD
Bortezomib—PSMB5—cortex of kidney—chronic kidney failure	0.00136	0.0126	CbGeAlD
Bortezomib—PSMB2—nephron tubule—chronic kidney failure	0.00135	0.0126	CbGeAlD
Bortezomib—PSMD2—digestive system—chronic kidney failure	0.00134	0.0125	CbGeAlD
Bortezomib—PSMD2—blood—chronic kidney failure	0.00128	0.0119	CbGeAlD
Bortezomib—PSMB8—blood—chronic kidney failure	0.00127	0.0119	CbGeAlD
Bortezomib—PSMB1—renal system—chronic kidney failure	0.00126	0.0117	CbGeAlD
Bortezomib—PSMB1—cardiovascular system—chronic kidney failure	0.00124	0.0116	CbGeAlD
Bortezomib—PSMB1—urethra—chronic kidney failure	0.00124	0.0115	CbGeAlD
Bortezomib—PSMB2—renal system—chronic kidney failure	0.00123	0.0114	CbGeAlD
Bortezomib—PSMB1—kidney—chronic kidney failure	0.00122	0.0113	CbGeAlD
Bortezomib—PSMB2—cardiovascular system—chronic kidney failure	0.00121	0.0113	CbGeAlD
Bortezomib—PSMB2—urethra—chronic kidney failure	0.00121	0.0112	CbGeAlD
Bortezomib—PSMB2—kidney—chronic kidney failure	0.00119	0.0111	CbGeAlD
Bortezomib—PSMB1—cortex of kidney—chronic kidney failure	0.00118	0.011	CbGeAlD
Bortezomib—SLC31A1—nephron tubule—chronic kidney failure	0.00117	0.0109	CbGeAlD
Bortezomib—PSMB2—cortex of kidney—chronic kidney failure	0.00116	0.0108	CbGeAlD
Bortezomib—PSMB1—gonad—chronic kidney failure	0.00113	0.0105	CbGeAlD
Bortezomib—PSMB5—blood—chronic kidney failure	0.00112	0.0105	CbGeAlD
Bortezomib—PSMB2—gonad—chronic kidney failure	0.0011	0.0103	CbGeAlD
Bortezomib—CYP3A4—urine—chronic kidney failure	0.00108	0.0101	CbGeAlD
Bortezomib—CYP2D6—urine—chronic kidney failure	0.00107	0.00993	CbGeAlD
Bortezomib—SLC31A1—renal system—chronic kidney failure	0.00106	0.0099	CbGeAlD
Bortezomib—SLC31A1—urethra—chronic kidney failure	0.00104	0.00973	CbGeAlD
Bortezomib—PSMB1—digestive system—chronic kidney failure	0.00103	0.00961	CbGeAlD
Bortezomib—SLC31A1—kidney—chronic kidney failure	0.00103	0.00957	CbGeAlD
Bortezomib—PSMB2—digestive system—chronic kidney failure	0.00101	0.00938	CbGeAlD
Bortezomib—SLC31A1—cortex of kidney—chronic kidney failure	0.001	0.00932	CbGeAlD
Bortezomib—PSMB1—blood—chronic kidney failure	0.000983	0.00916	CbGeAlD
Bortezomib—PSMB2—blood—chronic kidney failure	0.000959	0.00894	CbGeAlD
Bortezomib—CYP2C19—blood plasma—chronic kidney failure	0.000956	0.0089	CbGeAlD
Bortezomib—SLC31A1—gonad—chronic kidney failure	0.000953	0.00888	CbGeAlD
Bortezomib—PTGS1—artery—chronic kidney failure	0.000902	0.0084	CbGeAlD
Bortezomib—SLC31A1—digestive system—chronic kidney failure	0.000872	0.00812	CbGeAlD
Bortezomib—CYP2C8—blood plasma—chronic kidney failure	0.000834	0.00777	CbGeAlD
Bortezomib—SLC31A1—blood—chronic kidney failure	0.000831	0.00774	CbGeAlD
Bortezomib—CYP1A2—blood plasma—chronic kidney failure	0.000781	0.00727	CbGeAlD
Bortezomib—CYP2C9—blood plasma—chronic kidney failure	0.000741	0.0069	CbGeAlD
Bortezomib—PTGS1—blood plasma—chronic kidney failure	0.000677	0.0063	CbGeAlD
Bortezomib—CYP3A4—blood plasma—chronic kidney failure	0.000565	0.00526	CbGeAlD
Bortezomib—CYP2D6—blood plasma—chronic kidney failure	0.000556	0.00518	CbGeAlD
Bortezomib—Nateglinide—PTGS1—chronic kidney failure	0.000486	0.478	CrCbGaD
Bortezomib—CYP2C8—renal system—chronic kidney failure	0.000391	0.00364	CbGeAlD
Bortezomib—CYP2C8—kidney—chronic kidney failure	0.000378	0.00352	CbGeAlD
Bortezomib—CYP2C19—digestive system—chronic kidney failure	0.000368	0.00342	CbGeAlD
Bortezomib—CYP1A2—renal system—chronic kidney failure	0.000366	0.00341	CbGeAlD
Bortezomib—CYP1A1—renal system—chronic kidney failure	0.000361	0.00336	CbGeAlD
Bortezomib—CYP1A1—urethra—chronic kidney failure	0.000355	0.0033	CbGeAlD
Bortezomib—CYP2C19—blood—chronic kidney failure	0.00035	0.00326	CbGeAlD
Bortezomib—CYP1A1—kidney—chronic kidney failure	0.000349	0.00325	CbGeAlD
Bortezomib—CYP2C9—cardiovascular system—chronic kidney failure	0.000343	0.0032	CbGeAlD
Bortezomib—PTGS1—renal system—chronic kidney failure	0.000317	0.00295	CbGeAlD
Bortezomib—PTGS1—cardiovascular system—chronic kidney failure	0.000313	0.00292	CbGeAlD
Bortezomib—PTGS1—kidney—chronic kidney failure	0.000307	0.00286	CbGeAlD
Bortezomib—CYP2C8—blood—chronic kidney failure	0.000306	0.00285	CbGeAlD
Bortezomib—CYP1A2—digestive system—chronic kidney failure	0.0003	0.0028	CbGeAlD
Bortezomib—CYP1A1—digestive system—chronic kidney failure	0.000296	0.00276	CbGeAlD
Bortezomib—CYP1A2—blood—chronic kidney failure	0.000286	0.00266	CbGeAlD
Bortezomib—CYP2C9—digestive system—chronic kidney failure	0.000285	0.00265	CbGeAlD
Bortezomib—Nateglinide—CYP3A4—chronic kidney failure	0.000284	0.279	CrCbGaD
Bortezomib—CYP1A1—blood—chronic kidney failure	0.000282	0.00263	CbGeAlD
Bortezomib—CYP2C9—blood—chronic kidney failure	0.000271	0.00253	CbGeAlD
Bortezomib—CYP3A4—renal system—chronic kidney failure	0.000265	0.00247	CbGeAlD
Bortezomib—CYP2D6—renal system—chronic kidney failure	0.000261	0.00243	CbGeAlD
Bortezomib—PTGS1—digestive system—chronic kidney failure	0.00026	0.00242	CbGeAlD
Bortezomib—CYP3A4—kidney—chronic kidney failure	0.000256	0.00239	CbGeAlD
Bortezomib—CYP2D6—kidney—chronic kidney failure	0.000252	0.00235	CbGeAlD
Bortezomib—PTGS1—blood—chronic kidney failure	0.000248	0.00231	CbGeAlD
Bortezomib—Nateglinide—ALB—chronic kidney failure	0.000248	0.243	CrCbGaD
Bortezomib—CYP3A4—digestive system—chronic kidney failure	0.000217	0.00202	CbGeAlD
Bortezomib—CYP2D6—digestive system—chronic kidney failure	0.000214	0.00199	CbGeAlD
Bortezomib—CYP3A4—blood—chronic kidney failure	0.000207	0.00193	CbGeAlD
Bortezomib—CYP2D6—blood—chronic kidney failure	0.000204	0.0019	CbGeAlD
Bortezomib—PSMD1—Signaling Pathways—NFKB1—chronic kidney failure	8.15e-06	4.39e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	8.13e-06	4.37e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	8.11e-06	4.37e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—NFKB1—chronic kidney failure	8.11e-06	4.36e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—LRP2—chronic kidney failure	8.09e-06	4.35e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CYP2C18—chronic kidney failure	8.09e-06	4.35e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	8.08e-06	4.35e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—SERPINE1—chronic kidney failure	8.07e-06	4.34e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—SREBF1—chronic kidney failure	8.06e-06	4.34e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PRKD1—chronic kidney failure	7.97e-06	4.29e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CYP2B6—chronic kidney failure	7.97e-06	4.29e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PRKAG2—chronic kidney failure	7.97e-06	4.29e-05	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—IL6—chronic kidney failure	7.95e-06	4.28e-05	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—IL6—chronic kidney failure	7.91e-06	4.26e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—SLC22A2—chronic kidney failure	7.9e-06	4.25e-05	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—IL6—chronic kidney failure	7.87e-06	4.24e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	7.85e-06	4.22e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—HMGCR—chronic kidney failure	7.84e-06	4.22e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—NOS3—chronic kidney failure	7.81e-06	4.21e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—NOS3—chronic kidney failure	7.81e-06	4.21e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—NOS3—chronic kidney failure	7.81e-06	4.21e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—LPL—chronic kidney failure	7.78e-06	4.19e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—NOS3—chronic kidney failure	7.7e-06	4.15e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—FASN—chronic kidney failure	7.67e-06	4.13e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—SCARB1—chronic kidney failure	7.61e-06	4.1e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	7.58e-06	4.08e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CPT1A—chronic kidney failure	7.54e-06	4.06e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PTGS1—chronic kidney failure	7.53e-06	4.05e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—CYP1A1—chronic kidney failure	7.51e-06	4.05e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—SREBF2—chronic kidney failure	7.47e-06	4.02e-05	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—VEGFA—chronic kidney failure	7.43e-06	4e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	7.41e-06	3.99e-05	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—KRAS—chronic kidney failure	7.4e-06	3.99e-05	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—KRAS—chronic kidney failure	7.4e-06	3.99e-05	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—KRAS—chronic kidney failure	7.4e-06	3.99e-05	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—VEGFA—chronic kidney failure	7.39e-06	3.98e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—SREBF1—chronic kidney failure	7.39e-06	3.98e-05	CbGpPWpGaD
Bortezomib—PSMB1—Disease—TGFB1—chronic kidney failure	7.38e-06	3.97e-05	CbGpPWpGaD
Bortezomib—PSMB5—Disease—TGFB1—chronic kidney failure	7.38e-06	3.97e-05	CbGpPWpGaD
Bortezomib—PSMB2—Disease—TGFB1—chronic kidney failure	7.38e-06	3.97e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—VEGFA—chronic kidney failure	7.36e-06	3.96e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—RELA—chronic kidney failure	7.36e-06	3.96e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—RELA—chronic kidney failure	7.36e-06	3.96e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—RELA—chronic kidney failure	7.36e-06	3.96e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—LIPC—chronic kidney failure	7.35e-06	3.96e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ABCG1—chronic kidney failure	7.34e-06	3.95e-05	CbGpPWpGaD
Bortezomib—PSMA1—Disease—IL6—chronic kidney failure	7.34e-06	3.95e-05	CbGpPWpGaD
Bortezomib—PSMD1—Disease—IL6—chronic kidney failure	7.3e-06	3.93e-05	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—KRAS—chronic kidney failure	7.3e-06	3.93e-05	CbGpPWpGaD
Bortezomib—PSMB8—Disease—TGFB1—chronic kidney failure	7.27e-06	3.92e-05	CbGpPWpGaD
Bortezomib—PSMD2—Disease—IL6—chronic kidney failure	7.27e-06	3.91e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	7.25e-06	3.9e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—RELA—chronic kidney failure	7.25e-06	3.9e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GCKR—chronic kidney failure	7.21e-06	3.88e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ABCC3—chronic kidney failure	7.21e-06	3.88e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—HMGCR—chronic kidney failure	7.19e-06	3.87e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PIP5K1B—chronic kidney failure	7.18e-06	3.87e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—CYP3A4—chronic kidney failure	7.11e-06	3.83e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	7.07e-06	3.81e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—LPIN1—chronic kidney failure	7.06e-06	3.8e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ARG2—chronic kidney failure	7.04e-06	3.79e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—FASN—chronic kidney failure	7.03e-06	3.79e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—MTHFR—chronic kidney failure	7.01e-06	3.77e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—ABCA1—chronic kidney failure	6.99e-06	3.76e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CPT1A—chronic kidney failure	6.94e-06	3.73e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	6.93e-06	3.73e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—LRP2—chronic kidney failure	6.91e-06	3.72e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CYP2C18—chronic kidney failure	6.91e-06	3.72e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—LCAT—chronic kidney failure	6.9e-06	3.72e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CPT1A—chronic kidney failure	6.88e-06	3.7e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PPARA—chronic kidney failure	6.87e-06	3.7e-05	CbGpPWpGaD
Bortezomib—PSMB1—Disease—KRAS—chronic kidney failure	6.83e-06	3.68e-05	CbGpPWpGaD
Bortezomib—PSMB2—Disease—KRAS—chronic kidney failure	6.83e-06	3.68e-05	CbGpPWpGaD
Bortezomib—PSMB5—Disease—KRAS—chronic kidney failure	6.83e-06	3.68e-05	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—TGFB1—chronic kidney failure	6.82e-06	3.67e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—SCARB1—chronic kidney failure	6.79e-06	3.66e-05	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—TGFB1—chronic kidney failure	6.79e-06	3.65e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CYP2C19—chronic kidney failure	6.76e-06	3.64e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—LIPC—chronic kidney failure	6.76e-06	3.64e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—TGFB1—chronic kidney failure	6.75e-06	3.64e-05	CbGpPWpGaD
Bortezomib—PSMB8—Disease—KRAS—chronic kidney failure	6.74e-06	3.63e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PTGS1—chronic kidney failure	6.72e-06	3.62e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—LIPC—chronic kidney failure	6.7e-06	3.61e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CYP2C19—chronic kidney failure	6.7e-06	3.61e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	6.61e-06	3.56e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	6.61e-06	3.56e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—SREBF1—chronic kidney failure	6.59e-06	3.55e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—CYP3A4—chronic kidney failure	6.51e-06	3.51e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	6.48e-06	3.49e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—HMGCR—chronic kidney failure	6.41e-06	3.45e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—ABCA1—chronic kidney failure	6.4e-06	3.45e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—DDC—chronic kidney failure	6.34e-06	3.41e-05	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—KRAS—chronic kidney failure	6.32e-06	3.4e-05	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—KRAS—chronic kidney failure	6.29e-06	3.38e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—FASN—chronic kidney failure	6.28e-06	3.38e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—KRAS—chronic kidney failure	6.26e-06	3.37e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—SCARB1—chronic kidney failure	6.25e-06	3.36e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—NFKB1—chronic kidney failure	6.2e-06	3.34e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—NFKB1—chronic kidney failure	6.2e-06	3.34e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—NFKB1—chronic kidney failure	6.2e-06	3.34e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—SCARB1—chronic kidney failure	6.19e-06	3.33e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PTGS1—chronic kidney failure	6.18e-06	3.33e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CYP2B6—chronic kidney failure	6.15e-06	3.31e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PRKD1—chronic kidney failure	6.15e-06	3.31e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PRKAG2—chronic kidney failure	6.15e-06	3.31e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PTGS1—chronic kidney failure	6.13e-06	3.3e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—NFKB1—chronic kidney failure	6.12e-06	3.29e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—SREBF1—chronic kidney failure	6.06e-06	3.26e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	6.03e-06	3.25e-05	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—IL6—chronic kidney failure	6.02e-06	3.24e-05	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—IL6—chronic kidney failure	6.02e-06	3.24e-05	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—IL6—chronic kidney failure	6.02e-06	3.24e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—SREBF1—chronic kidney failure	6.01e-06	3.24e-05	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—IL6—chronic kidney failure	5.94e-06	3.2e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—CAT—chronic kidney failure	5.91e-06	3.18e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—HMGCR—chronic kidney failure	5.9e-06	3.18e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CPT1A—chronic kidney failure	5.88e-06	3.16e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—HMGCR—chronic kidney failure	5.85e-06	3.15e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CYP3A4—chronic kidney failure	5.81e-06	3.13e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	5.79e-06	3.11e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—FASN—chronic kidney failure	5.77e-06	3.11e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—SREBF2—chronic kidney failure	5.76e-06	3.1e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—ABCB1—chronic kidney failure	5.75e-06	3.1e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—LIPC—chronic kidney failure	5.73e-06	3.08e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CYP2C19—chronic kidney failure	5.73e-06	3.08e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—FASN—chronic kidney failure	5.72e-06	3.08e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—ABCA1—chronic kidney failure	5.72e-06	3.08e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	5.65e-06	3.04e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—VEGFA—chronic kidney failure	5.63e-06	3.03e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—VEGFA—chronic kidney failure	5.63e-06	3.03e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—VEGFA—chronic kidney failure	5.63e-06	3.03e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—POMC—chronic kidney failure	5.6e-06	3.02e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GCKR—chronic kidney failure	5.56e-06	3e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ABCC3—chronic kidney failure	5.56e-06	3e-05	CbGpPWpGaD
Bortezomib—PSMB2—Disease—IL6—chronic kidney failure	5.56e-06	2.99e-05	CbGpPWpGaD
Bortezomib—PSMB5—Disease—IL6—chronic kidney failure	5.56e-06	2.99e-05	CbGpPWpGaD
Bortezomib—PSMB1—Disease—IL6—chronic kidney failure	5.56e-06	2.99e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—VEGFA—chronic kidney failure	5.55e-06	2.99e-05	CbGpPWpGaD
Bortezomib—PSMB8—Disease—IL6—chronic kidney failure	5.48e-06	2.95e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—LPL—chronic kidney failure	5.48e-06	2.95e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—LPIN1—chronic kidney failure	5.45e-06	2.93e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—CAT—chronic kidney failure	5.42e-06	2.92e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CYP3A4—chronic kidney failure	5.35e-06	2.88e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CYP2C18—chronic kidney failure	5.33e-06	2.87e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—LRP2—chronic kidney failure	5.33e-06	2.87e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CYP3A4—chronic kidney failure	5.3e-06	2.85e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—SCARB1—chronic kidney failure	5.29e-06	2.85e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	5.27e-06	2.84e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—ABCB1—chronic kidney failure	5.27e-06	2.84e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—ABCA1—chronic kidney failure	5.26e-06	2.83e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PTGS1—chronic kidney failure	5.24e-06	2.82e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—ABCA1—chronic kidney failure	5.21e-06	2.81e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—TGFB1—chronic kidney failure	5.17e-06	2.78e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—TGFB1—chronic kidney failure	5.17e-06	2.78e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—TGFB1—chronic kidney failure	5.17e-06	2.78e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	5.15e-06	2.77e-05	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—IL6—chronic kidney failure	5.14e-06	2.77e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—SREBF1—chronic kidney failure	5.14e-06	2.77e-05	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—IL6—chronic kidney failure	5.11e-06	2.75e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—ALB—chronic kidney failure	5.11e-06	2.75e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—TGFB1—chronic kidney failure	5.09e-06	2.74e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—IL6—chronic kidney failure	5.09e-06	2.74e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—LPL—chronic kidney failure	5.03e-06	2.71e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—HMGCR—chronic kidney failure	5e-06	2.69e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—MTHFR—chronic kidney failure	4.94e-06	2.66e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—FASN—chronic kidney failure	4.89e-06	2.63e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—NOS3—chronic kidney failure	4.89e-06	2.63e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—CYP1A1—chronic kidney failure	4.85e-06	2.61e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PPARA—chronic kidney failure	4.84e-06	2.61e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CAT—chronic kidney failure	4.84e-06	2.61e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—KRAS—chronic kidney failure	4.79e-06	2.58e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—KRAS—chronic kidney failure	4.79e-06	2.58e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—KRAS—chronic kidney failure	4.79e-06	2.58e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—KRAS—chronic kidney failure	4.72e-06	2.54e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—ABCB1—chronic kidney failure	4.71e-06	2.53e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CPT1A—chronic kidney failure	4.54e-06	2.44e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CYP3A4—chronic kidney failure	4.53e-06	2.44e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—MTHFR—chronic kidney failure	4.52e-06	2.44e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	4.51e-06	2.43e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—LPL—chronic kidney failure	4.49e-06	2.41e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PTGS2—chronic kidney failure	4.47e-06	2.41e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ABCA1—chronic kidney failure	4.45e-06	2.4e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CAT—chronic kidney failure	4.45e-06	2.4e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PPARA—chronic kidney failure	4.44e-06	2.39e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—LIPC—chronic kidney failure	4.42e-06	2.38e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CYP2C19—chronic kidney failure	4.42e-06	2.38e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CAT—chronic kidney failure	4.41e-06	2.38e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CYP1A1—chronic kidney failure	4.33e-06	2.33e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—ABCB1—chronic kidney failure	4.33e-06	2.33e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—ABCB1—chronic kidney failure	4.29e-06	2.31e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—LPL—chronic kidney failure	4.13e-06	2.22e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—LPL—chronic kidney failure	4.09e-06	2.2e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—SCARB1—chronic kidney failure	4.08e-06	2.2e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PTGS1—chronic kidney failure	4.04e-06	2.18e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—MTHFR—chronic kidney failure	4.04e-06	2.17e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CYP1A1—chronic kidney failure	3.98e-06	2.15e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—SREBF1—chronic kidney failure	3.96e-06	2.13e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PPARA—chronic kidney failure	3.96e-06	2.13e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CYP1A1—chronic kidney failure	3.95e-06	2.13e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—POMC—chronic kidney failure	3.95e-06	2.12e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—IL6—chronic kidney failure	3.89e-06	2.1e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—IL6—chronic kidney failure	3.89e-06	2.1e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—IL6—chronic kidney failure	3.89e-06	2.1e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—HMGCR—chronic kidney failure	3.86e-06	2.08e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—IL6—chronic kidney failure	3.84e-06	2.07e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—FASN—chronic kidney failure	3.77e-06	2.03e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CAT—chronic kidney failure	3.77e-06	2.03e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—MTHFR—chronic kidney failure	3.71e-06	2e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—MTHFR—chronic kidney failure	3.68e-06	1.98e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ABCB1—chronic kidney failure	3.67e-06	1.97e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PPARA—chronic kidney failure	3.64e-06	1.96e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—POMC—chronic kidney failure	3.62e-06	1.95e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PPARA—chronic kidney failure	3.61e-06	1.94e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—ALB—chronic kidney failure	3.6e-06	1.94e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—LPL—chronic kidney failure	3.5e-06	1.88e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—NOS3—chronic kidney failure	3.44e-06	1.85e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ABCA1—chronic kidney failure	3.44e-06	1.85e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CYP1A1—chronic kidney failure	3.38e-06	1.82e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—ALB—chronic kidney failure	3.3e-06	1.78e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—POMC—chronic kidney failure	3.23e-06	1.74e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—NOS3—chronic kidney failure	3.16e-06	1.7e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PTGS2—chronic kidney failure	3.15e-06	1.69e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—MTHFR—chronic kidney failure	3.15e-06	1.69e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PPARA—chronic kidney failure	3.09e-06	1.66e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—POMC—chronic kidney failure	2.97e-06	1.6e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—POMC—chronic kidney failure	2.95e-06	1.59e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—ALB—chronic kidney failure	2.94e-06	1.59e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CAT—chronic kidney failure	2.91e-06	1.57e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PTGS2—chronic kidney failure	2.89e-06	1.55e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ABCB1—chronic kidney failure	2.83e-06	1.52e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—NOS3—chronic kidney failure	2.82e-06	1.52e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—ALB—chronic kidney failure	2.71e-06	1.46e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—LPL—chronic kidney failure	2.7e-06	1.45e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—ALB—chronic kidney failure	2.69e-06	1.45e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CYP1A1—chronic kidney failure	2.61e-06	1.4e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—NOS3—chronic kidney failure	2.59e-06	1.39e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PTGS2—chronic kidney failure	2.58e-06	1.39e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—NOS3—chronic kidney failure	2.57e-06	1.38e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—POMC—chronic kidney failure	2.52e-06	1.35e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—MTHFR—chronic kidney failure	2.43e-06	1.31e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PPARA—chronic kidney failure	2.38e-06	1.28e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PTGS2—chronic kidney failure	2.37e-06	1.28e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PTGS2—chronic kidney failure	2.35e-06	1.26e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ALB—chronic kidney failure	2.29e-06	1.24e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—NOS3—chronic kidney failure	2.19e-06	1.18e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PTGS2—chronic kidney failure	2.01e-06	1.08e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—POMC—chronic kidney failure	1.94e-06	1.05e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ALB—chronic kidney failure	1.77e-06	9.53e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—NOS3—chronic kidney failure	1.69e-06	9.12e-06	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PTGS2—chronic kidney failure	1.55e-06	8.34e-06	CbGpPWpGaD
